-

Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe

Our booth will demonstrate seamlessly connected automation and intelligent software powered by AI

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company’s Thermo Fisher™ Connect Platform can integrate and future-proof laboratories.

"Our Mission at Thermo Fisher Scientific is to enable our customers to make the world healthier, cleaner and safer, and this means helping scientists achieve their goals more effectively, moving beyond routine tasks to focus on what really matters."

Share

From Digital Ambition to Automated Intelligence

In pharma and life sciences, digital transformation is no longer a question of if — but how fast. Many labs remain stuck in a cycle of technical debt and shadow IT. By leveraging Thermo Fisher’s capabilities in digital solutions and advanced automation, the Connect Platform moves laboratories from basic digitization to full orchestration. It connects instruments, systems and data across labs to create a unified environment and increase productivity.

“Our Mission at Thermo Fisher Scientific is to enable our customers to make the world healthier, cleaner and safer, and this means helping scientists achieve their goals more effectively, moving beyond routine tasks to focus on what really matters: discovery, insight and impact,” said Mark Fish, vice president and general manager of Digital Science and Automation Solutions, Thermo Fisher Scientific.

At Lab of the Future Europe, Thermo Fisher is demonstrating how that Mission informs our Connect Platform to tangibly upgrade labs across the globe. Attendees can engage with the company in the following ways in Amsterdam:

  • Listen to a keynote presentation by Mark Fish: “Key Ingredients for Building the Automated Digital Labs of the Future.” (Tuesday, September 30)
  • Attend a track presentation by Martin Hornshaw, senior director, scientific collaboration, enterprise science and innovation partnerships: “Customer Case Studies, Enterprise Science and Innovation for Scaled Business Outcomes.” (Wednesday, October 1)
  • Visit us at booth C3 to learn more about our digital and automation offerings.

The Power of Partnership

Also announced this week is a strategic partnership between Thermo Fisher and BenchSci, a pioneer in AI for life sciences research. The companies will develop AI-powered research tools and digital capabilities to accelerate experimental design and improve R&D productivity for scientists and researchers. Visit our booth at Lab of the Future Europe to learn more.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)


Contacts

Media Contact Information:
Alex Runner
Thermo Fisher Scientific
alex.runner@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desig...

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000%...

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors wi...
Back to Newsroom